Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Coya Therapeutics, Inc.

NASDAQ: COYA · Life Sciences · 5 alerts · CIK 1835022

Share price
$3.00Close, Nov 16
Market cap
$70.4M
Shares outstanding
23.46MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Coya Therapeutics, Inc. filings on SEC EDGAR ↗

8:30 AM ET 8-K
Business Update

Coya Therapeutics Business Update

Coya Therapeutics announced plans to initiate an open-label extension for its Phase 2/3 ALSTARS trial of COYA 302 in ALS to collect long-term safety and efficacy data. Due to resource prioritization for the ALS program, the company has delayed the planned initiation of its Phase 2 trial for COYA 302 in frontotemporal dementia from late 2026 to 2027.

8:15 AM ET 8-K
Business Update

Coya Therapeutics Business Update

Coya Therapeutics announced it has enrolled the 100th patient in its Phase 2/3 ALSTARS trial evaluating COYA 302 for the treatment of ALS. The company expects to complete full enrollment of 120 participants shortly and remains on track to report topline data in early Q2 2027.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.